Recent Quarter Total Invested
$16.59 M
Recent Quarter Institutional Ownership Percentage
30.28%
Total Invested of Last Quarter
$45.39 M
Ownership Percentage of Last Quarter
71.92%
Aligos Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 08/14/2024 | 7.26 M | $2.54 M | 5.27% | 4.65% |
| ECOR1 CAPITAL, LLC | 08/14/2024 | 6.39 M | $2.24 M | 0.00% | 4.09% |
| DEEP TRACK CAPITAL, LP | 08/14/2024 | 6.10 M | $2.14 M | 0.00% | 3.91% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2024 | 5.00 M | $1.75 M | 102.88% | 3.20% |
| VIVO CAPITAL, LLC | 08/14/2024 | 3.55 M | $1.24 M | 0.00% | 2.27% |
| HHLR ADVISORS, LTD. | 08/14/2024 | 3.12 M | $1.09 M | 63.77% | 2.00% |
| BAKER BROS. ADVISORS LP | 08/14/2024 | 2.08 M | $726,740 | 0.00% | 1.33% |
| TANG CAPITAL MANAGEMENT LLC | 08/14/2024 | 1.65 M | $577,500 | 0.00% | 1.06% |
| VANGUARD GROUP INC | 08/13/2024 | 1.60 M | $558,376 | 57.48% | 1.02% |
| VERSANT VENTURE MANAGEMENT, LLC | 08/07/2024 | 1.46 M | $510,278 | -37.17% | 0.93% |
| OPALEYE MANAGEMENT INC. | 08/14/2024 | 1.26 M | $441,000 | -22.70% | 0.81% |
| UBS OCONNOR LLC | 08/14/2024 | 1.00 M | $350,000 | 100.00% | 0.64% |
| ACADIAN ASSET MANAGEMENT LLC | 08/06/2024 | 829,485 | $289,000 | 26.06% | 0.53% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 816,029 | $285,610 | -28.90% | 0.52% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 768,839 | $269,094 | -4.88% | 0.49% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 08/13/2024 | 743,215 | $260,125 | 0.00% | 0.48% |
| NEWTYN MANAGEMENT, LLC | 08/14/2024 | 719,287 | $251,750 | -40.06% | 0.46% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 08/14/2024 | 655,515 | $229,430 | 0.00% | 0.42% |
| WOODLINE PARTNERS LP | 08/14/2024 | 531,204 | $185,921 | 100.00% | 0.34% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 405,694 | $142,022 | 8.75% | 0.26% |
| ALYESKA INVESTMENT GROUP, L.P. | 08/14/2024 | 284,233 | $99,482 | 100.00% | 0.18% |
| CITADEL ADVISORS LLC | 08/14/2024 | 277,363 | $97,077 | -2.91% | 0.18% |
| BLACKROCK INC. | 08/13/2024 | 227,406 | $79,592 | -25.14% | 0.15% |
| STATE STREET CORP | 08/14/2024 | 107,123 | $37,493 | 9.96% | 0.07% |
| NORTHERN TRUST CORP | 08/14/2024 | 91,950 | $32,183 | -0.07% | 0.06% |
| LMR PARTNERS LLP | 08/14/2024 | 50,000 | $17,500 | 100.00% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/13/2024 | 46,476 | $16,267 | 479.36% | 0.03% |
| XTX TOPCO LTD | 08/12/2024 | 35,644 | $12,475 | -20.56% | 0.02% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 31,383 | $10,984 | 0.00% | 0.02% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 29,881 | $10,458 | -73.00% | 0.02% |
| CHOATE INVESTMENT ADVISORS | 08/08/2024 | 24,000 | $8,400 | 0.00% | 0.02% |
| PRUDENTIAL FINANCIAL INC | 08/13/2024 | 19,600 | $6,860 | 100.00% | 0.01% |
| HARBOURVEST PARTNERS LLC | 08/14/2024 | 18,783 | $6,574 | 0.00% | 0.01% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 18,706 | $6,547 | 0.44% | 0.01% |
| CWM, LLC | 07/10/2024 | 16,891 | $6,000 | 0.00% | 0.01% |
| ZWJ INVESTMENT COUNSEL INC | 07/19/2024 | 14,500 | $5,075 | 0.00% | 0.01% |
| JANE STREET GROUP, LLC | 08/15/2024 | 13,666 | $4,783 | 100.00% | 0.01% |
| ZULLO INVESTMENT GROUP, INC. | 08/13/2024 | 13,000 | $4,550 | 0.00% | 0.01% |
| VIRTU FINANCIAL LLC | 08/09/2024 | 12,306 | $4,000 | 100.00% | 0.01% |
| CREATIVE PLANNING | 08/15/2024 | 10,050 | $3,518 | -35.27% | 0.01% |
| HIGHTOWER ADVISORS, LLC | 08/13/2024 | 10,000 | $4,000 | 100.00% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 08/13/2024 | 5,500 | $1,925 | 100.00% | 0.00% |
| MORGAN STANLEY | 08/14/2024 | 3,300 | $1,155 | 0.00% | 0.00% |
| CITADEL ADVISORS LLC | 08/14/2024 | 1,400 | $490 | -63.16% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2024 | 677 | $237 | 0.00% | 0.00% |
| UBS GROUP AG | 08/14/2024 | 362 | $127 | -96.66% | 0.00% |
| CITADEL ADVISORS LLC | 08/14/2024 | 300 | $105 | 50.00% | 0.00% |
| ZRC WEALTH MANAGEMENT, LLC | 07/09/2024 | 100 | $35,000 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
Aligos Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of ALGS shares?
During the previous two years, 60 institutional investors and hedge funds held shares of Aligos Therapeutics, Inc.. The most heavily invested institutionals were:
ARMISTICE CAPITAL, LLC: 7.26 M
EcoR1 Capital, LLC: 6.39 M
Deep Track Capital, LP: 6.1 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 5 M
Vivo Capital, LLC: 3.55 M
HHLR ADVISORS, LTD.: 3.12 M
-
What percentage of Aligos Therapeutics, Inc. stock is owned by institutional investors?
30.28% of Aligos Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at ALGS ?
Institutional investors have bought a total of 50.35 M shares in the last 24 months. This purchase volume represents approximately $423.42 M in transactions.